Developments in T Cell Based Cancer Immunotherapies (Springer International Publishing, 2015)
1 New insight of peptide vaccination in cancer immunotherapy – 2 The determinants of T cell function for effective anticancer vaccine – 3 T cell fate in the tumor microenvironment – 4 T cell receptor avidity and affinity and tumor specific TCR engineer – 5 Host genetic variation and somatic alteration associated with favorable or compromised T cell function – 6 Production of Clinical T Cell Therapies – 7 Clinical success of adoptive cell transfer therapy using tumor infiltrating lymphocytes.-8 Harnessing stem cell-like memory T cells for adoptive cell transfer therapy of cancer – 9 T cell blockade- anti-CTLA4 immunotherapy against cancer and Abscopal effect in combination therapy – 10 T cell modulation- anti-OD-1 antibodies for the treatment of cancer – 11 T cell based therapies in combination with other procedures – 12 Chimeric antigen receptor T cells CD19 CAR – 13 Hematopoietic Stem Cell transplantation as immune therapy of malignancies